An expert in infertility and microsurgery explains how to interpret semen analysis in Part 1 of a two-part series on male infertility. He also tells why much traditional treatment of male infertility, including varicocelectomy, is pointless.
Letters discuss the myriad of issues affecting the practice of specialties. Joshua A. Copel responds.
The American Board of Obstetrics and Gynecology stopped issuing their usual certificates in 2008 and have switched to a "maintenance of certification" protocol that requires all ob/gyns to walk through a more demanding 6-year process involving CME offerings, a written examination, and chart reviews.
Anyone who's been practicing ob/gyn for more than 20 years knows that our profession has changed tremendously, and largely to our great frustration.
Despite the prevalence of GSM, the condition continues to be under-recognized and undertreated due to a combination of patient and provider factors. Providers need to take the initiative in screening and patient education.
Results presented at the 2019 AAGL Congress demonstrated a higher rate of UTI among younger patients with increased estimated blood loss (EBL) following the procedure.
Although traditional drugs work for most patients, potential side effects turn some patients off. Examining the evidence, two experts argue for trying approaches like magnetic and electrical stimulation, acupuncture, or Botox.
Ashley S. Roman, MD, MPH, reviews some of the new updates discussed in ACOG Practice Bulletin #203: Chronic Hypertension in Pregnancy.
To guide health-care providers about the role of calcium in peri-and postmenopausal women, The North American Menopause Society recently developed an evidence-based statement.
When I started practicing "menopause medicine" 40 years ago, Dr. Robert Wilson's book, Feminine Forever was on the bestseller list. Today, as I approach the pinnacle of my career, Suzanne Somers' Ageless: The Naked Truth About Bioidentical Hormones is on the shelves. The titles are different but the message is the same: the promise of eternal youth . . . .
I truly believe that "Protocols for High-Risk Pregnancies" has contributed to improving perinatal care.
As fetal electrocardiograph analysis comes of age, there's a growing body of research to suggest it can serve as a valuable adjunct to traditional EFM. Here's an expert review on the technology and the data supporting it.
A rigorous assessment of who, when, and how to screen may lead to regular testing in a broader population.
These recommendations, based on the observations of a patient, is a Top 8 list of ways to optimize an outpatient visit for reproductive health care for women with spinal cord injury or disease.
Misconceptions about oral contraceptives, the vaginal ring, and the transdermal patch can deprive patients of their full benefits.
Data from the FASTER and BUN trials show that first-trimester NT measurement can reveal a lot more than just trisomy 21. Although not ready for prime time as a screening test for congenital heart disease, we can't ignore the strong association between increased NT and an elevated risk of several cardiac birth defects and to a lesser degree diaphragmatic hernia. But what can we do about it?
Oxytocin is one of the most frequently used drugs during labor but it can also become a major issue in a malpractice case filed after a labor and delivery if there is an adverse outcome. PLUS: Carolyn Zelop, MD, provides commentary on a lawsuit involving a patient death during pregnancy due to cardiomyopathy.
An expert in obstetrics and gynecology comments on the utilization of GnRH agonists and GnRH antagonists in COS in IVF treatment.
Snapshot: Protocol 18 - Peripartum Cardiomyopathy
Diagnosing and treating women with vulvar vestibulitis can sometimes seem more art than science. Here an expert reviews the available evidence and describes his approach.
Protocol 5 - In this protocol, Norton reviews the pathophysiology of fetal aneuploidy and the wide range of tests for it. Included are perspectives on cell-free DNA testing, first-trimester combined screening, nuchal translucency (NT) sonography, and pregnancy-associated plasma protein A (PAPP-A) and human chorionic gonadotropin (hCG), as well as quad marker screening in the second trimester in appropriate cases, and combined first- and second-trimester screening.
Learning that she has what used to be called premature menopause can devastate a woman in her 20s or 30s. Diagnose this mysterious condition without delay, deliver the bad news in person, and provide sensitiveanswers to four basic questions.
If choosing gender is okay before fertilization, why shouldn't it be with PGD after fertilization, is the thrust of the "pro" argument. The other side calls PGD gender discrimination.
Complications following IUD removal were the focus of this lawsuit.
It is essential to expand access to all available, effective cervical cancer screening options for the most vulnerable populations. The targeted use of any particular screening modality in higher-risk populations is not supported by evidence-based guidelines; any effective screening is the priority.
For many women, the 50s are a milestone decade. In addition to other changes, menopause can bring about sexual dysfunction.
Urinary incontinence can often be successfully treated without referral, but first ob/gyns need to broach the subject! Two experts tell how to evaluate this widespread condition.